Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Most herbal polyphenols and flavonoids reveals multiple ameliorative benefits for obesity caused by chronic metabolic disorders. Accumulated studies have revealed that preferable therapeutic effects can be obtained through clinical combination of the
Externí odkaz:
https://doaj.org/article/6d6b06f668d1406f9811844633b0fe1e
Autor:
Jiamin Wu, Yi Li, Jiayao Yu, Zhending Gan, Wenyao Wei, Chao Wang, Lili Zhang, Tian Wang, Xiang Zhong
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Purpose:N6-methyladenosine (m6A) mRNA methylation is affected by dietary factors and associated with lipid metabolism; however, whether the regulatory role of resveratrol in lipid metabolism is involved in m6A mRNA methylation remains unknown. Here,
Externí odkaz:
https://doaj.org/article/207e3340bffc4e66a64a2f8d1f973b61
Autor:
Yuhei eNishimura, Shota eSasagawa, Michiko eAriyoshi, Sayuri eIchikawa, Yasuhito eShimada, Koki eKawaguchi, Reiko eKawase, Reiko eYamamoto, Takuma eUehara, Takaaki eYanai, Ryoji eTakata, Toshio eTanaka
Publikováno v:
Frontiers in Pharmacology, Vol 6 (2015)
Both caloric restriction and resveratrol have beneficial effects on obesity. However, the biochemical pathways that mediate these beneficial effects might be complex and interconnected and have not been fully elucidated. To reveal the common therapeu
Externí odkaz:
https://doaj.org/article/c422d8c7bf6042d682479fbba5141439
Autor:
Ivana eZagotta, Elitsa Y. eDimova, Klaus-Michael eDebatin, Martin eWabitsch, Thomas eKietzmann, Pamela eFischer-Posovszky
Publikováno v:
Frontiers in Pharmacology, Vol 6 (2015)
Obesity is associated with an inflammatory status and linked with a number of pathophysiological complications among them cardiovascular disease, type 2 diabetes mellitus, or the metabolic syndrome. Resveratrol was proposed to improve obesity-related
Externí odkaz:
https://doaj.org/article/ee50fabc375543f09559ec4254732d1f